Loading insider details...
Beta
Latest Form 4 (Jul 7, 2026): Exercise/Conversion of 14,801 INMB shares, $20.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Inmune Bio, Inc. (INMB) | Exercise/Conversion | 14,801 | $20.7K |
| Dec 2, 2025 | Inmune Bio, Inc. (INMB) | Grant/Award | 150,000 | n/a |
| Nov 18, 2025 | Inmune Bio, Inc. (INMB) | Disposition to Issuer | 108,000 | n/a |
| Dec 9, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 32,500 | n/a |
| Jun 26, 2024 | Inmune Bio, Inc. (INMB) | Purchase | 5,000 | $36.4K |
| May 16, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 12,500 | n/a |
| Apr 23, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 29,603 | $246.3K |
| Nov 13, 2023 | Inmune Bio, Inc. (INMB) | Purchase | 7,000 | $48.6K |
| Feb 21, 2023 | Inmune Bio, Inc. (INMB) | Grant/Award | 35,000 | n/a |
| Mar 23, 2022 | Inmune Bio, Inc. (INMB) | Grant/Award | 35,000 | n/a |